Free Trial
One Day Left! MarketBeat All Access Returns to $249 Soon
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Elevance Health (ELV) Earnings Date, Estimates & Call Transcripts

Elevance Health logo
$421.48 +7.07 (+1.71%)
Closing price 03:59 PM Eastern
Extended Trading
$418.64 -2.84 (-0.67%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elevance Health Earnings Summary

Elevance Health announced Q3 2026 earnings on October 21, 2026, reporting an EPS of $6.99, which topped analysts' consensus estimates of $4.71 by $2.28. Quarterly revenue rose .7% year-over-year to $50.44 billion, above the consensus estimate of $49.28 billion. With a trailing EPS of $23.45 and a P/E Ratio of 13.65, Elevance Health's earnings are expected to grow 1.75% next year, from $29.13 to $29.64 per share.

Latest Q3
Earnings Date
Oct. 21Estimated
Consensus EPS
(Oct. 21)
$4.71
Actual EPS
(Oct. 21)
$6.99 Beat By $2.28
Actual Revenue
(Oct. 21)
$50.44B

Q3 2026 Earnings Resources

Get Elevance Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elevance Health and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ELV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevance Health Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS Guidance
Q1 20263$10.10$12.79$11.10
Q2 20264$6.15$11.52$8.03
Q3 20264$4.60$9.87$6.43
Q4 20264$2.43$5.03$3.32
FY 202615$23.28$39.21$28.87
Q1 20273$10.05$13.01$11.71
Q2 20273$6.74$9.62$7.93
Q3 20273$5.53$7.56$6.60
Q4 20272$3.56$4.66$4.11
FY 202711$25.88$34.85$30.35
Q1 20281$11.15$11.15$11.15
Q2 20281$8.22$8.22$8.22

Elevance Health Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/21/2026Q3 2026$4.71$6.99+$2.28$6.27$49.28B$50.44B
7/15/2026Q2 2026$6.21$7.45+$1.24$6.71$48.88B$49.83B
4/22/2026Q1 2026$10.74$12.58+$1.84$8.00$48.21B$49.49B
1/28/2026Q4 2025$3.10$3.33+$0.23$2.47$49.52B$49.31B
10/21/2025Q3 2025$5.03$6.03+$1.00$5.32$49.26B$50.09B
7/17/2025Q2 2025$9.30$8.84 -$0.46$7.72$48.26B$49.42B
4/22/2025Q1 2025$10.60$11.97+$1.37$9.61$46.26B$48.77B
1/23/2025Q4 2024$3.80$3.84+$0.04$1.81$44.63B$44.99B

Elevance Health Earnings - Frequently Asked Questions

Elevance Health (NYSE:ELV) last announced its quarterly earning data on Wednesday, October 21, 2026. Learn more on ELV's earnings history.

Elevance Health updated its FY 2026 earnings guidance on Saturday, September, 19th. The company provided earnings per share (EPS) guidance of 27.000- for the period, compared to the consensus estimate of 27.160. The company issued revenue guidance of -.

In the previous quarter, Elevance Health (NYSE:ELV) reported $6.99 earnings per share (EPS) to beat the analysts' consensus estimate of $4.71 by $2.28. Learn more on analysts' earnings estimate vs. ELV's actual earnings.

The conference call for Elevance Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Elevance Health's latest earnings report can be read online.
Read Transcript

Elevance Health's earnings report can be found in their filing with the SEC.
View SEC filing

Elevance Health (NYSE:ELV) has a recorded annual revenue of $199.13 billion.

Elevance Health (NYSE:ELV) has a recorded net income of $5.66 billion. ELV has generated $23.45 earnings per share over the last four quarters.

Elevance Health (NYSE:ELV) has a trailing price-to-earnings ratio of 13.65 and a forward price-to-earnings ratio of 14.47. The price/earnings-to-growth ratio is 1.98.

Elevance Health's earnings are expected to grow from $29.13 per share to $29.64 per share in the next year, which is a 1.75% increase.


Earnings data for NYSE:ELV is sourced from Fiscal.ai, with the most recent quarter reported on 10/21/2026. New results are added as companies report their earnings.
From Our Partners